8-K - IOVANCE BIOTHERAPEUTICS, INC. (0001425205) (Filer)
Published . Updated .
8-K - IOVANCE BIOTHERAPEUTICS filed an 8-K with the SEC on Oct 29 (a notice of a material company event).
Directly affected
- IOVA Iovance Biotherapeutics-8.6% 30d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Iovance Biotherapeutics belongs to, so it often moves with news about it.
- AMGN Amgen+18.4% 30d
Amgen is a peer of Iovance Biotherapeutics in biological products, (no diagnostic substances); rivals often move on the same news.
- GILD Gilead Sciences+16.6% 30d
Gilead Sciences is a peer of Iovance Biotherapeutics in biological products, (no diagnostic substances); rivals often move on the same news.
- MRNA Moderna+28.2% 30d
Moderna is a peer of Iovance Biotherapeutics in biological products, (no diagnostic substances); rivals often move on the same news.
- ARGX argenx SE-17.4% 17d
argenx SE is a peer of Iovance Biotherapeutics in biological products, (no diagnostic substances); rivals often move on the same news.
- RVMD Revolution Medicines
Revolution Medicines is a peer of Iovance Biotherapeutics in biological products, (no diagnostic substances); rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| IOVA | +47.54% | +52.78% | base | -11.27% | -16.61% | after close | after close |
| XLVNo price data for this ticker | — | — | — | — | — | — | — |
| AMGNNo price data for this ticker | — | — | — | — | — | — | — |
| GILDNo price data for this ticker | — | — | — | — | — | — | — |
| MRNANo price data for this ticker | — | — | — | — | — | — | — |
| ARGXNo price data for this ticker | — | — | — | — | — | — | — |
| RVMDNo price data for this ticker | — | — | — | — | — | — | — |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Filed: 2026-10-29 AccNo: 0001104659-26-120261 Size: 233 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
Price since this story was published: Iovance Biotherapeutics (IOVA)
| Company | When | Move | Status |
|---|---|---|---|
| Iovance Biotherapeutics (IOVA) | that day | -11.27% | final price |
| Iovance Biotherapeutics (IOVA) | the next day | -16.61% | still updating |
| Iovance Biotherapeutics (IOVA) | three days earlier | +52.78% | final price |
| Iovance Biotherapeutics (IOVA) | five days earlier | +47.54% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. David J. Taylor bought Amgen (AMGN), worth $1,001 - $15,000 on 22 Sep 2026. That is 37 days before publication. Filed 1 Oct 2026. View the filing.
- Rep. David J. Taylor sold Amgen (AMGN), worth $1,001 - $15,000 on 26 Aug 2026. That is 64 days before publication. Filed 5 Sep 2026. View the filing.
- Sen. Sheldon Whitehouse sold Amgen (AMGN) (held by a spouse), worth $1,001 - $15,000 on 12 Aug 2026. That is 78 days before publication. Filed 2 Sep 2026. View the filing.
- Rep. Rohit Khanna sold Gilead Sciences (GILD) (held by a dependent child), worth $1,001 - $15,000 on 10 Aug 2026. That is 80 days before publication. Filed 4 Sep 2026. View the filing.
- Rep. Maria Elvira Salazar sold Moderna (MRNA), worth $1,001 - $15,000 on 24 Sep 2026. That is 35 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Moderna (MRNA) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 55 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Moderna (MRNA), worth $1,001 - $15,000 on 28 Aug 2026. That is 62 days before publication. Filed 8 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “8-K - IOVANCE BIOTHERAPEUTICS, INC. (0001425205) (Filer)”
Companies carried with this story
- IOVA Iovance Biotherapeutics
For “8-K - IOVANCE BIOTHERAPEUTICS, INC. (0001425205) (Filer),” Iovance Biotherapeutics (IOVA) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> IOVA
How “8-K - IOVANCE BIOTHERAPEUTICS, INC. (0001425205) (Filer)” reaches Iovance Biotherapeutics (IOVA)
On 29 Oct 2026, “8-K - IOVANCE BIOTHERAPEUTICS, INC. (0001425205) (Filer)” is the story that connects Iovance Biotherapeutics (IOVA) to this story.
The link for Iovance Biotherapeutics (IOVA) is this: SEC 8-K filing -> direct issuer disclosure -> IOVA
Price levels for Iovance Biotherapeutics (IOVA)
IOVA traded between 8.27 and 15.35 across 20 sessions. The latest close on file is 8.47.
What the saved facts support for Iovance Biotherapeutics (IOVA)
14 out of 100Price not final
“8-K - IOVANCE BIOTHERAPEUTICS, INC. (0001425205) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies. The price is not final yet.